Skip to main content
. 2021 Feb 16;96(7):e1024–e1035. doi: 10.1212/WNL.0000000000011409

Table 3.

Adverse Events (AEs) in ≥5% of Individuals in any Treatment Group by Preferred Term, Safety Set

graphic file with name NEUROLOGY2020070516TT3.jpg